Study Stopped
end of inclusion period
Tinnitus Related Cerebral Activities
ACCELA
1 other identifier
interventional
24
0 countries
N/A
Brief Summary
The proposed research is to identify the brain areas activated or deactivated by tinnitus in humans. The identification of these areas is expected to be able to treat tinnitus refractory to traditional therapies by methods of brain stimulation. Furthermore, this technique would be very useful to verify the effectiveness of any treatment to relieve tinnitus. The brain activation measured during fMRI will be performed in a position of rest, after inhibition of tinnitus, and after application of a sound that does not inhibit tinnitus. This comparison will identify specific brain areas activated or deactivated by tinnitus.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Feb 2013
Typical duration for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 5, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 27, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
August 27, 2015
CompletedFirst Submitted
Initial submission to the registry
July 27, 2016
CompletedFirst Posted
Study publicly available on registry
August 3, 2016
CompletedDecember 28, 2021
December 1, 2021
2.6 years
July 27, 2016
December 27, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Measure of the BOLD activity by MRI
Measure is done by MRI
6 months
Secondary Outcomes (1)
Measure of the BOLD activity on resting state by MRI
6 months
Study Arms (1)
single sided tinnitus
OTHERpatients with single sided tinnitus on which functional brain MRI is assessed
Interventions
Sound evoked functional MRI assessment on patients with single sided tinnitus
Eligibility Criteria
You may qualify if:
- Age limits to \> 18 years and \< 70 years
- Voluntary study participation
- Unhurt of any acute or chronic pathology of the ear (except tinnitus and a possible deafness of perception in the limits fixed below) on the basis of the interrogation and of the clinical examination
- presenting a single sided tinnitus
- Presenting on the side of the tinnitus a phenomenon of residual inhibition with a duration of total disappearance of the tinnitus of more than 30 seconds
- easily reached
- informed consent signed
- Affiliation or recipient with the mode of social security
You may not qualify if:
- Subjects incapable to understand the nature and the purposes of the study and/or having difficulty of communication with the investigator
- majors protected by the law or privated of liberty by judiciary or administrative decision
- pregnant woman
- Anomaly of the external or average ear
- Tinnitus attributed to a clearly identified retro-cochlear origin
- Deafness of transmission of more than 15 dB on the tonal audiometry
- Deafness of perception of more than 60 dB in average hearing loss (arithmetic mean) on the frequencies of 0,5-1-2 and 4 kHz.
- Renowned ototoxic treatment during the duration of the protocol (malaria medicines, ototoxic chemotherapy, ototoxic antibiotic treatment),
- Pursuit of a noise exposure of strong intensity with title professional and/or of leisure, dental treatment with use of engine or turbine, during the duration of the protocol.
- Contraindication in the examination MRI (pacemaker, port of surgical clips in the cervico-cephalic region or implanted medical surgical material susceptible to mobilize under the influence of magnetic gradients, foreign body intraocular, pieces of shrapnel at the cervico-cephalic level (possibility of artefact), claustrophobia, pregnancy of less than 3 months)
- History of cranial trauma with encephalic infringement(achievement), ischemic cerebrovascular accident or intracerebral bruise.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Frederic Venail, MD PhD
CHU de Montpellier
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 27, 2016
First Posted
August 3, 2016
Study Start
February 5, 2013
Primary Completion
August 27, 2015
Study Completion
August 27, 2015
Last Updated
December 28, 2021
Record last verified: 2021-12
Data Sharing
- IPD Sharing
- Will not share